January is Alzheimer Awareness Month

CAMH expert available for media interviews

TORONTO, Jan. 17, 2013 /CNW/ - Alzheimer disease already affects close to half a million Canadians, yet we still don't know the cause.  With a senior population expected to approach seven million by 2021, new research and treatment options for the disease are crucial.

The Centre for Addiction and Mental Health (CAMH) is placing itself in a strong position to address the challenges of Alzheimer disease.  There is good reason to be hopeful.

From brain stimulation to enhance neuro-plasticity, to the establishment of a brain bank dedicated to collecting and distributing donor tissue for research, CAMH is at the forefront of new cutting edge science promising to advance the treatment options for the millions of people around the world living with Alzheimer disease.

Tarek Rajji, Chief of Geriatric Psychiatry at CAMH is available for interviews to discuss Alzheimer disease, current treatment and on-going research.

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in its field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental health and addiction issues. CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit www.camh.ca.

SOURCE: Centre for Addiction and Mental Health

Michael Torres, CAMH Media Relations, 416-595-6015 or [email protected]​